• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Symptoms of COVID-19 Outpatients in the United States

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2020 Jun 30;7(7):ofaa271.
doi: 10.1093/ofid/ofaa271. eCollection 2020 Jul.
Symptoms of COVID-19 Outpatients in the United States


Matthew F Pullen[SUP] 1 [/SUP], Caleb P Skipper[SUP] 1 [/SUP], Kathy H Hullsiek[SUP] 2 [/SUP], Ananta S Bangdiwala[SUP] 2 [/SUP], Katelyn A Pastick[SUP] 1 [/SUP], Elizabeth C Okafor[SUP] 1 [/SUP], Sarah M Lofgren[SUP] 1 [/SUP], Radha Rajasingham[SUP] 1 [/SUP], Nicole W Engen[SUP] 2 [/SUP], Alison Galdys[SUP] 1 [/SUP], Darlisha A Williams[SUP] 1 [/SUP], Mahsa Abassi[SUP] 1 [/SUP], David R Boulware[SUP] 1 2 [/SUP]



Affiliations

Abstract

Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel pathogen causing the current worldwide coronavirus disease 2019 (COVID-19) pandemic. Due to insufficient diagnostic testing in the United States, there is a need for clinical decision-making algorithms to guide testing prioritization.
Methods: We recruited participants nationwide for a randomized clinical trial. We categorized participants into 3 groups: (1) those with confirmed SARS-CoV-2 infection, (2) those with probable SARS-CoV-2 infection (pending test or not tested but with a confirmed COVID-19 contact), and (3) those with possible SARS-CoV-2 infection (pending test or not tested and with a contact for whom testing was pending or not performed). We compared the frequency of self-reported symptoms in each group and categorized those reporting symptoms in early infection (0-2 days), midinfection (3-5 days), and late infection (>5 days).
Results: Among 1252 symptomatic persons screened, 316 had confirmed, 393 had probable, and 543 had possible SARS-CoV-2 infection. In early infection, those with confirmed and probable SARS-CoV-2 infection shared similar symptom profiles, with fever most likely in confirmed cases (P = .002). Confirmed cases did not show any statistically significant differences compared with unconfirmed cases in symptom frequency at any time point. The most commonly reported symptoms in those with confirmed infection were cough (82%), fever (67%), fatigue (62%), and headache (60%), with only 52% reporting both fever and cough.
Conclusions: Symptomatic persons with probable SARS-CoV-2 infection present similarly to those with confirmed SARS-CoV-2 infection. There was no pattern of symptom frequency over time.

Keywords: COVID-19; SARS-CoV-2; coronavirus.
 
Back
Top Bottom